Filing Details
- Accession Number:
- 0001209191-20-058057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 17:26:57
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-12 17:26:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551306 | Progyny Inc. | PGNY | Services-Misc Health & Allied Services, Nec (8090) | 272220139 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1789513 | Jennifer Bealer | C/O Progyny, Inc. 1359 Broadway, 2Nd Fl New York NY 10018 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-09 | 632 | $3.96 | 66,238 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-11-09 | 3,437 | $3.96 | 69,675 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-09 | 2,267 | $30.02 | 67,408 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-11-09 | 1,802 | $30.05 | 65,606 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-11-09 | 632 | $0.00 | 632 | $3.96 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-11-09 | 3,437 | $0.00 | 3,437 | $3.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
18,343 | 2029-05-21 | No | 4 | M | Direct | |
106,564 | 2029-05-23 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 15, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.04 to $30.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- One-fourth (1/4th) of the shares subject to the Option vested on March 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.